United Nations Office on Drugs and Crime. World Drug Report 2021; Booklet 1; Executive summary Policy implications https://www.unodc.org/res/wdr2021/field/WDR21_Booklet_1.pdf (2021).
Mahboub, N., Rizk, R., Karavetian, M. & de Vries, N. Nutritional status and eating habits of people who use drugs and/or are undergoing treatment for recovery: a narrative review. Nutr. Rev. 79, 627–635 (2020).
el-Nakah, A., Frank, O., Louria, D. B., Quinones, M. A. & Baker, H. A vitamin profile of heroin addiction. Am. J. Public Health 69, 1058–1060 (1979).
Himmelgreen, D. A. et al. A comparison of the nutritional status and food security of drug-using and non-drug-using hispanic women in hartford connecticut. Am. J. Phys. Anthropol. 107, 351–361 (1998).
Saeland, M. et al. High sugar consumption and poor nutrient intake among drug addicts in Oslo Norway. Br. J. Nutr. 105, 618–624 (2011).
Neale, J., Nettleton, S., Pickering, L. & Fischer, J. Eating patterns among heroin users: a qualitative study with implications for nutritional interventions. Addiction 107, 635–641 (2012).
Zador, D., Lyons Wall, P. M. & Webster, I. High sugar intake in a group of women on methadone maintenance in south western Sydney Australia. Addiction 91, 1053–1061 (1996).
Kheradmand, A. & Kheradmand, A. Nutritional status in patients under methadone maintenance treatment. J Subst Use 25, 173–176 (2020).
Nolan, L. J. & Scagnelli, L. M. Preference for sweet foods and higher body mass index in patients being treated in long-term methadone maintenance. Subst. Use Misuse. 42, 1555–1566 (2007).
LeFevre, M. L. & LeFevre, N. M. Vitamin D screening and supplementation in community-dwelling adults: common questions and answers. Am. Fam. Physician. 97, 254–260 (2018).
Kim, T. W., Alford, D. P., Holick, M. F., Malabanan, A. O. & Samet, J. H. Low vitamin D status of patients in methadone maintenance treatment. J. Addict. Med. 3, 134–138 (2009).
Reece, A. S. & Hulse, G. K. What are the characteristics of vitamin D metabolism in opioid dependence? An exploratory longitudinal study in Australian primary care. BMJ Open 8, 016806. https://doi.org/10.1136/bmjopen-2017-016806 (2018).
Yazici, A. B. et al. Comparison of vitamin B12, vitamin D and folic acid blood levels in patients with schizophrenia, drug addiction and controls. J. Clin. Neurosci. 65, 11–16 (2019).
Norman, A. W. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am. J. Clin Nutr. 88, 491s–499s (2008).
Holick, M. F. Vitamin D deficiency. N. Engl. J. Med. 357, 266–281 (2007).
Zerwekh, J. E. Blood biomarkers of vitamin D status. Am. J. Clin. Nutr. 87, 1087S-1091S (2008).
Ross AC, Taylor CL, Yaktine AL, Del Valle HB; Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press (2011).
Holick, M. F. et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 1911–1930 (2011).
Holick, M. F. & Chen, T. C. Vitamin D deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr. 87, 1080s–1086s (2008).
Rimmelzwaan, L. M., van Schoor, N. M., Lips, P., Berendse, H. W. & Eekhoff, E. M. Systematic review of the relationship between vitamin D and parkinson’s disease. J. Parkinsons. Dis. 6, 29–37 (2016).
Galyuk, T. M. & Loonen, A. J. M. Putative role of vitamin D in the mechanism of alcoholism and other addictions: a hypothesis. Acta. Neuropsychiatr. 33, 1–8 (2021).
Kemény, L. V. et al. Vitamin D deficiency exacerbates UV/endorphin and opioid addiction. Sci. Adv. 7, 4577. https://doi.org/10.1126/sciadv.abe4577 (2021).
Kim, Y. et al. Perioperative serum 25-hydroxyvitamin d levels as a predictor of postoperative opioid use and opioid use disorder: a cohort study. J. Gen. Intern. Med. 35, 2545–2552 (2020).
Fadnes, L. T. et al. Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV). BMC Infect. Dis. 19, 943. https://doi.org/10.1186/s12879-019-4598-7 (2019).
Helse Bergen. ATLAS4LAR: Kartlegging og behandling av lungesykdom i legemiddelassistert behandling https://helse-bergen.no/avdelinger/rusmedisin/rusmedisin-seksjon-forsking/bar/atlas4lar-kartlegging-og-behandling-av-lungesykdom-i-legemiddelassistert-behandling (2019).
Haukeland universitetssjukehus; Helse Bergen. Analyseoversikten: 25(OH)vitamin D, https://analyseoversikten.no/analyse/11 (2021).
Stavanger Universitetssjukehus; Helse Stavanger. Laboratoriehåndbok: Vitamin D (25-OH-vitamin D, 25-hydroksyvitamin D i serum) https://labhandbok.sus.no/docs/doc_28356/index.html (2020).
World Health Organization. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence https://www.who.int/publications/i/item/9789241547543 (2009).
Vold, J. H. et al. Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020. Subst. Abuse Treat Prev. Policy 16, 67. https://doi.org/10.1186/s13011-021-00403-9 (2021).
Christensen, M. H., Lien, E. A., Hustad, S. & Almås, B. Seasonal and age-related differences in serum 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone in patients from Western Norway. Scand. J. Clin. Lab. Invest. 70, 281–286 (2010).
Larose, T. L. et al. Factors associated with vitamin D deficiency in a Norwegian population: the HUNT Study. J. Epidemiol. Community Health 68, 165–170 (2014).
Petrenya, N., Lamberg-Allardt, C., Melhus, M., Broderstad, A. R. & Brustad, M. Vitamin D status in a multi-ethnic population of northern Norway: the SAMINOR 2 clinical Survey. Public Health Nutr. 23, 1186–1200 (2020).
Sophocleous, A. et al. Heavy cannabis use is associated with low bone mineral density and an increased risk of fractures. Am. J. Med. 130, 214–221 (2017).
Vold, J. H. et al. Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020. Subst. Abuse Treat Prev. Policy 15, 93. https://doi.org/10.1186/s13011-020-00334-x (2020).
Aas, C. F. et al. Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway. Subst. Abuse Treat Prev. Policy 16, 20 (2021).
Brock, K. et al. Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women. J. Steroid. Biochem. Mol. Biol. 121, 462–466 (2010).
Holick, M. F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr. 80, 1678s–1688s (2004).
Hossein-nezhad, A. & Holick, M. F. Vitamin D for health: a global perspective. Mayo. Clin. Proc. 88, 720–755 (2013).
Ghaderi, A. et al. Clinical trial of the effects of vitamin D supplementation on psychological symptoms and metabolic profiles in maintenance methadone treatment patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 79, 84–89 (2017).
Roth, D. E. et al. Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low- and middle-income countries. Ann. N Y Acad. Sci. 1430, 44–79 (2018).